Abstract:Background Pulmonary perfusion defects have been observed in patients with coronavirus disease 2019 (COVID‐19). Currently, there is a need for further data on non‐contrast‐enhanced MRI in COVID patients. The early identification of heterogeneity in pulmonary perfusion defects among COVID‐19 patients is beneficial for their timely clinical intervention and management. Purpose To investigate the utility of phase‐resolved functional lung (PREFUL) MRI in detecting pulmonary perfusion disturbances in individuals with postacute COVID‐19 syndrome (PACS). Study Type Prospective. Subjects Forty‐four participants (19 females, mean age 64.1 years) with PACS and 44 healthy subjects (19 females, mean age 59.5 years). Moreover, among the 44 patients, there were 19 inpatients and 25 outpatients; 19 were female and 25 were male; 18 with non‐dyspnea and 26 with dyspnea. Field Strength/Sequence 3‐T, two‐dimensional (2D) spoiled gradient‐echo sequence. Assessment Ventilation and perfusion‐weighted maps were extracted from five coronal slices using PREFUL analysis. Subsequently, perfusion defect percentage (QDP), ventilation defect percentage (VDP), and ventilation‐perfusion match healthy (VQM) were calculated based on segmented lung parenchyma ventilation and perfusion‐weighted maps. Additionally, clinical features, including demographic data (such as sex and age) and serum biomarkers (such as D‐dimer levels), were evaluated. Statistical Tests Spearman correlation coefficients to explore relationships between clinical features and QDP, VDP, and VQM. Propensity score matching analysis to reduce the confounding bias between patients with PACS and healthy controls. The Mann–Whitney U tests and Chi‐squared tests to detect differences between groups. Multivariable linear regression analyses to identify factors related to QDP, VDP, and VQM. A P‐value <0.05 was considered statistically significant. Results QDP significantly exceeded that of healthy controls in individuals with PACS (39.8% ± 15.0% vs. 11.0% ± 4.9%) and was significantly higher in inpatients than in outpatients (46.8% ± 17.0% vs. 34.5% ± 10.8%). Moreover, males exhibited pulmonary perfusion defects significantly more frequently than females (43.9% ± 16.8% vs. 34.4% ± 10.2%), and dyspneic participants displayed significantly higher perfusion defects than non‐dyspneic patients (44.8% ± 15.8% vs. 32.6% ± 10.3%). QDP showed a significant positive relationship with age (β = 0.50) and D‐dimer level (β = 0.72). Data Conclusion PREFUL MRI may show pulmonary perfusion defects in patients with PACS. Furthermore, perfusion impairments may be more pronounced in males, inpatients, and dyspneic patients. Evidence Level 2 Technical Efficacy Stage 2

Sequence comparison of spoiled gradient echo and balanced steady‐state free precession for pulmonary free‐breathing proton MRI in patients and healthy volunteers: Correspondence, repeatability, and validation with dynamic contrast‐enhanced MRI

Comparison of Free‐Breathing 3D Phase‐Resolved Functional Lung (PREFUL) MRI With Dynamic 19F Ventilation MRI in Patients With Obstructive Lung Disease and Healthy Volunteers

Influence of gadolinium, field-strength and sequence type on quantified perfusion values in phase-resolved functional lung MRI

Free-breathing 3D phase-resolved functional lung MRI vs breath-hold hyperpolarized 129Xe ventilation MRI in patients with chronic obstructive pulmonary disease and healthy volunteers

Phase-resolved MRI for measurement of pulmonary perfusion and ventilation defects in comparison with dynamic contrast-enhanced MRI and 129Xe MRI

Phase-Resolved Functional Lung MRI for Pulmonary Ventilation and Perfusion (V/Q) Assessment

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Free-breathing Dynamic Contrast-Enhanced MRI for Assessment of Pulmonary Lesions Using Golden-Angle Radial Sparse Parallel Imaging.

Influence of echo time on pulmonary ventilation and perfusion derived by phase‐resolved functional lung (PREFUL) MRI using multi‐echo ultrashort echo time acquisition

Feasibility of flow-related enhancement brain perfusion MRI

Comparison of 3D UTE free-breathing lung MRI with hyperpolarized 129Xe MRI in pediatric cystic fibrosis

Phase-Resolved Functional Lung (PREFUL) MRI to Quantify Ventilation: Feasibility and Physiological Relevance in Severe Asthma

Free‐Breathing Functional Pulmonary Proton MRI: A Novel Approach Using Voxel‐Wise Lung Ventilation (VOLVE) Assessment in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease

Unsupervised clustering algorithms improve the reproducibility of dynamic contrast-enhanced magnetic resonance imaging pulmonary perfusion quantification in muco-obstructive lung diseases

Estimating ventilation correlation coefficients in the lungs using PREFUL‐MRI in chronic obstructive pulmonary disease patients and healthy adults

Three-dimensional Free-Breathing Whole-Heart Coronary Magnetic Resonance Angiography at 1.5 T: Gadobutrol-Enhanced Gradient-Echo Acquisition Sequence Versus Non-contrast-Enhanced Steady-State Free Precession Sequence.

3D quantitative myocardial perfusion imaging with hyperpolarized HP001(bis‐1,1‐(hydroxymethyl)‐[1‐13C]cyclopropane‐d8): Application of gradient echo and balanced SSFP sequences

Comparison of Imaging Quality of 2-Dimensional Double Inversion Recovery Fast Spin Echo Black-Blood Cardiac MR Sequence with Phase Ordering with Automatic Window Selection and Simultaneous Multiple Volume Algorithm Double Navigator-Gated and Breathholding

Phase‐Resolved Functional Lung (PREFUL) MRI May Reveal Distinct Pulmonary Perfusion Defects in Postacute COVID‐19 Syndrome: Sex, Hospitalization, and Dyspnea Heterogeneity

Improving Dynamic Contrast-Enhanced MRI of the Lung Using Motion-Weighted Sparse Reconstruction: Initial Experiences in Patients

Evaluation of T2-prepared blood oxygenation level dependent functional magnetic resonance imaging with an event-related task: Hemodynamic response function and reproducibility